The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling

Prostaglandins and Other Lipid Mediators

Volumn 113-115, Issue , 2014, Pages 2-12

  Wagner, Karen ^a   Vito, Steve ^a   Inceoglu, Bora ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epoxy fatty acids (EpFAs); Epoxydocosapentanoic acids (EDP EpDPEs); Epoxyeicosatrienoic acids (EETs); Omega 3 fatty acids; Pain; Soluble epoxide hydrolase (sEH)

Indexed keywords

ANTINOCICEPTIVE AGENT; DRUG METABOLITE; EPOXIDE; EPOXY FATTY ACID; FATTY ACID DERIVATIVE; HYDROLASE INHIBITOR; LIPID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SOLUBLE EPOXIDE HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; EPOXIDE HYDROLASE; OMEGA 6 FATTY ACID;

ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HUMAN; IN VIVO STUDY; INFLAMMATORY PAIN; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; SIGNAL TRANSDUCTION; INFLAMMATION; METABOLISM; NOCICEPTIVE PAIN; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; INFLAMMATION; NOCICEPTION; NOCICEPTIVE PAIN; SIGNAL TRANSDUCTION;

EID: 84909999333     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.09.001     Document Type: Review

References (117)

1. L.M. Arterburn, E.B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am J Clin Nutr 83 6 Suppl. 2006 1467S 1476S
2. H. Shapiro Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids 68 3 2003 219 224
3. W.E. Connor Importance of n-3 fatty acids in health and disease Am J Clin Nutr 71 1 Suppl. 2000 171S 175S
4. S.M. Innis Dietary omega 3 fatty acids and the developing brain Brain Res 1237 2008 35 43
5. A.P. Simopoulos Evolutionary aspects of diet and essential fatty acids World Rev Nutr Diet 88 2001 18 27
6. A.P. Simopoulos The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease Asia Pac J Clin Nutr 17 Suppl. 1 2008 131 134
7. C.I. Svensson, M. Zattoni, and C.N. Serhan Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing J Exp Med 204 2 2007 245 252
8. D.B. Jump, S. Tripathy, and C.M. Depner Fatty acid-regulated transcription factors in the liver Annu Rev Nutr 33 2013 249 269
9. A. Konkel, and W.H. Schunck Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids Biochim Biophys Acta 1814 1 2011 210 222
10. H.U. Zeilhofer Prostanoids in nociception and pain Biochem Pharmacol 73 2 2007 165 174
11. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Annu Rev Pathol 3 2008 279 312
12. C. Zhang, and N.G. Bazan Lipid-mediated cell signaling protects against injury and neurodegeneration J Nutr 140 4 2010 858 863
13. R.A. Lewis, K.F. Austen, and R.J. Soberman Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases N Engl J Med 323 10 1990 645 655
14. C. Arnold, A. Konkel, R. Fischer, and W.H. Schunck Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids Pharmacol Rep 62 3 2010 536 547
15. P. Sura, R. Sura, A.E. Enayetallah, and D.F. Grant Distribution and expression of soluble epoxide hydrolase in human brain J Histochem Cytochem 56 6 2008 551 559
16. J.J. Iliff, J. Jia, J. Nelson, T. Goyagi, J. Klaus, and N.J. Alkayed Epoxyeicosanoid signaling in CNS function and disease Prostaglandins Other Lipid Mediat 91 3-4 2010 68 84
17. G. Burdge Alpha-linolenic acid metabolism in men and women: nutritional and biological implications Curr Opin Clin Nutr Metab Care 7 2 2004 137 144
18. A.A. Farooqui, L.A. Horrocks, and T. Farooqui Deacylation and reacylation of neural membrane glycerophospholipids J Mol Neurosci 14 3 2000 123 135
19. I. Kudo, and M. Murakami Phospholipase A2 enzymes Prostaglandins Other Lipid Mediat 68-69 2002 3 58
20. C. Arnold, M. Markovic, and K. Blossey Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 43 2010 32720 32733
21. R. Fischer, A. Konkel, and H. Mehling Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway J Lipid Res 55 6 2014 1150 1164
22. A. Karara, E. Dishman, J.R. Falck, and J.H. Capdevila Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties J Biol Chem 266 12 1991 7561 7569
23. A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 1 2004 55 90
24. G.C. Shearer, W.S. Harris, T.L. Pedersen, and J.W. Newman Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters J Lipid Res 51 8 2010 2074 2081
25. F. Oesch Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds Xenobiotica 3 5 1973 305 340
26. A. Sevanian, R. Stein, and J. Mead Metabolism of epoxidized phosphatidylcholine by phospholipase A2 and epoxide hydrolase Lipids 16 11 1981 781 789
27. B. Borhan, T. Mebrahtu, S. Nazarian, M.J. Kurth, and B.D. Hammock Improved radiolabeled substrates for soluble epoxide hydrolase Anal Biochem 231 1 1995 188 200
28. D.E. Moody, K.A. Montgomery, M.B.A. Ashour, and B.D. Hammock Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes Biochem Pharmacol 41 11 1991 1625 1637
29. A. Marowsky, J. Burgener, J.R. Falck, J.M. Fritschy, and M. Arand Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism Neuroscience 163 2 2009 646 661
30. M. Decker, M. Arand, and A. Cronin Mammalian epoxide hydrolases in xenobiotic metabolism and signalling Arch Toxicol 83 4 2009 297 318
31. M. Decker, M. Adamska, and A. Cronin EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides J Lipid Res 53 10 2012 2038 2045
32. C. Morisseau, B. Inceoglu, and K. Schmelzer Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids J Lipid Res 51 12 2010 3481 3490
33. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 1 2002 131 185
34. N. Chiamvimonvat, C.M. Ho, H.J. Tsai, and B.D. Hammock The soluble epoxide hydrolase as a pharmaceutical target for hypertension J Cardiovasc Pharmacol 50 3 2007 225 237
35. K.R. Schmelzer, L. Kubala, J.W. Newman, I.H. Kim, J.P. Eiserich, and B.D. Hammock Soluble epoxide hydrolase is a therapeutic target for acute inflammation Proc Natl Acad Sci U S A 102 28 2005 9772 9777
36. B. Inceoglu, S.L. Jinks, and A. Ulu Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways Proc Natl Acad Sci U S A 105 48 2008 18901 18906
37. A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 Suppl. 2009 S52 S56
38. S.J. Thomson, A. Askari, and D. Bishop-Bailey Anti-inflammatory effects of epoxyeicosatrienoic acids Int J Vasc Med 2012 2012 7
39. S. Kundu, T. Roome, and A. Bhattacharjee Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo J Lipid Res 54 2 2013 436 447
40. M.F. Moghaddam, D.F. Grant, J.M. Cheek, J.F. Greene, K.C. Williamson, and B.D. Hammock Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase Nat Med 3 5 1997 562 566
41. J.N. Campbell, and R.A. Meyer Mechanisms of neuropathic pain Neuron 52 1 2006 77 92
42. C.J. Woolf, and Q. Ma Nociceptors - noxious stimulus detectors Neuron 55 3 2007 353 364
43. von Hehn, A. Christian, R. Baron, Woolf, and J. Clifford Deconstructing the neuropathic pain phenotype to reveal neural mechanisms Neuron 73 4 2012 638 652
44. Q. Xu, and T.L. Yaksh A brief comparison of the pathophysiology of inflammatory versus neuropathic pain Curr Opin Anaesthesiol 24 4 2011 400 407
45. J. Eritsland Safety considerations of polyunsaturated fatty acids Am J Clin Nutr 71 1 Suppl. 2000 197S 201S
46. M. Schlogelhofer, G.P. Amminger, and M.R. Schaefer Polyunsaturated fatty acids in emerging psychosis: a safer alternative? Early Interv Psychiatry 8 3 2014 199 208 10.1111/eip.12151 Epub 2014 May 27
47. T.L. Blasbalg, J.R. Hibbeln, C.E. Ramsden, S.F. Majchrzak, and R.R. Rawlings Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century Am J Clin Nutr 93 5 2011 950 962
48. K. Mayurasakorn, J.J. Williams, V.S. Ten, and R.J. Deckelbaum Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia Curr Opin Clin Nutr Metab Care 14 2 2011 158 167
49. M. Ouellet, V. Emond, and C.T. Chen Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study Neurochem Int 55 7 2009 476 482
50. T.A. Rix, J.H. Christensen, and E.B. Schmidt Omega-3 fatty acids and cardiac arrhythmias Curr Opin Clin Nutr Metab Care 16 2 2013 168 173
51. P.C. Calder n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases Am J Clin Nutr 83 6 Suppl. 2006 1505S 1519S
52. T.D. Niemoller, and N.G. Bazan Docosahexaenoic acid neurolipidomics Prostaglandins Other Lipid Mediat 91 3-4 2010 85 89
53. J.M. Kremer n-3 fatty acid supplements in rheumatoid arthritis Am J Clin Nutr 71 1 Suppl. 2000 349S 351S
54. R.J. Goldberg, and J. Katz A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain Pain 129 1-2 2007 210 223
55. K. Nakamoto, T. Nishinaka, M. Mankura, W. Fujita-Hamabe, and S. Tokuyama Antinociceptive effects of docosahexaenoic acid against various pain stimuli in mice Biol Pharm Bull 33 6 2010 1070 1072
56. M.E. Nobre, A.O. Correia, and B. Borges Mde Eicosapentaenoic acid and docosahexaenoic acid exert anti-inflammatory and antinociceptive effects in rodents at low doses Nutr Res 33 5 2013 422 433
57. P.A. Gerber, I. Gouni-Berthold, and K. Berneis Omega-3 fatty acids: role in metabolism and cardiovascular disease Curr Pharm Des 19 17 2013 3074 3093
58. + channels of neonatal rat ventricular myocytes Proc Natl Acad Sci U S A 92 24 1995 11000 11004
59. J.A. Matta, R.L. Miyares, and G.P. Ahern TRPV1 is a novel target for omega-3 polyunsaturated fatty acids J Physiol 578 Pt 2 2007 397 411
60. K. Nakamoto, T. Nishinaka, A. Ambo, M. Mankura, F. Kasuya, and S. Tokuyama Possible involvement of beta-endorphin in docosahexaenoic acid-induced antinociception Eur J Pharmacol 666 1-3 2011 100 104
61. P.C. Calder Polyunsaturated fatty acids and inflammation Prostaglandins Leukot Essent Fatty Acids 75 3 2006 197 202
62. S.H. Ferreira Prostaglandins, aspirin-like drugs and analgesia Nature 240 102 1972 200 203
63. R. Gonzales, M.E. Goldyne, Y.O. Taiwo, and J.D. Levine Production of hyperalgesic prostaglandins by sympathetic postganglionic neurons J Neurochem 53 5 1989 1595 1598
64. A.M. Torres-Guzman, C.E. Morado-Urbina, and P.A. Alvarado-Vazquez Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of complete Freund's adjuvant-induced knee arthritis Arthritis Res Ther 16 2 2014 R64
65. F.T. Nickel, F. Seifert, S. Lanz, and C. Maihöfner Mechanisms of neuropathic pain Eur Neuropsychopharmacol 22 2 2012 81 91
66. J.L. Edwards, A.M. Vincent, H.T. Cheng, and E.L. Feldman Diabetic neuropathy: mechanisms to management Pharmacol Ther 120 1 2008 1 34
67. D.F. Horrobin The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus Prostaglandins Leukot Essent Fatty Acids 31 3 1988 181 197
68. D. Raccah, M.F. Lamotte-Jannot, T. Issautier, and P. Vague Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney Diabetes Metab 20 3 1994 271 274
69. A. Gerbi, S. Sennoune, and S. Pierre Localization of Na,K-ATPase alpha/beta isoforms in rat sciatic nerves: effect of diabetes and fish oil treatment J Neurochem 73 2 1999 719 726
70. A. Gerbi, J.M. Maixent, and J.L. Ansaldi Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats J Nutr 129 1 1999 207 213
71. T.C. Coste, A. Gerbi, P. Vague, G. Pieroni, and D. Raccah Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy Diabetes 52 10 2003 2578 2585
72. T.L. Kaduce, Y. Chen, J.W. Hell, and A.A. Spector Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons J Neurochem 105 4 2008 1525 1535
73. A.T. Michael-Titus Omega-3 fatty acids and neurological injury Prostaglandins Leukot Essent Fatty Acids 77 5-6 2007 295 300
74. L. Shinto, J. Quinn, and T. Montine A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease J Alzheimers Dis 38 1 2014 111 120
75. A.I. Zugno, H.L. Chipindo, and A.M. Volpato Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia Neuroscience 259 0 2014 223 231
76. K.-P. Su, H.-C. Lai, and H.-T. Yang Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial Biol Psychiatry 76 7 2014 559 566
77. L. Arbabi, M.T.H. Baharuldin, M.A.M. Moklas, S. Fakurazi, and S.I. Muhammad Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats Behav Brain Res 271 2014 65 71
78. A.Y. Taha, W.M. Burnham, and S. Auvin Polyunsaturated fatty acids and epilepsy Epilepsia 51 8 2010 1348 1358
79. G. Zhang, D. Panigrahy, and L.M. Mahakian Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis Proc Natl Acad Sci U S A 110 16 2013 6530 6535
80. M. Bäck, S.-E. Dahlén, and J.M. Drazen International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions Pharmacol Rev 63 3 2011 539 584
81. D.F. Woodward, R.L. Jones, and S. Narumiya International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress Pharmacol Rev 63 3 2011 471 538
82. M. Terashvili, L.F. Tseng, and H.E. Wu Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray J Pharmacol Exp Ther 326 2 2008 614 622
83. J.L. Conroy, C. Fang, and J. Gu Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling Nat Neurosci 13 3 2010 284 286
84. H. Watanabe, J. Vriens, J. Prenen, G. Droogmans, T. Voets, and B. Nilius Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels Nature 424 6947 2003 434 438
85. 2+ signaling and hyperpolarization in endothelial cells Arterioscler Thromb Vasc Biol 27 12 2007 2612 2618
86. C. Brenneis, M. Sisignano, and O. Coste Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation Mol Pain 7 2011 78
87. B. Inceoglu, S.L. Jinks, K.R. Schmelzer, T. Waite, I.H. Kim, and B.D. Hammock Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain Life Sci 79 24 2006 2311 2319
88. K.R. Schmelzer, B. Inceoglu, and L. Kubala Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors Proc Natl Acad Sci U S A 103 37 2006 13646 13651
89. B. Inceoglu, K.R. Schmelzer, C. Morisseau, S.L. Jinks, and B.D. Hammock Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) Prostaglandins Other Lipid Mediat 82 1-4 2007 42 49
90. X. Wang, C.L. Shen, and M.T. Dyson The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression J Endocrinol 190 3 2006 871 878
91. K. Wagner, B. Inceoglu, S.S. Gill, and B.D. Hammock Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction J Agric Food Chem 59 7 2011 2816 2824
92. N.J. Alkayed, J. Narayanan, D. Gebremedhin, M. Medhora, R.J. Roman, and D.R. Harder Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes Stroke 27 5 1996 971 979
93. N.J. Alkayed, E.K. Birks, J. Narayanan, K.A. Petrie, A.E. Kohler-Cabot, and D.R. Harder Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats Stroke 28 5 1997 1066 1072
94. S.C. Amruthesh, M.F. Boerschel, J.S. McKinney, K.A. Willoughby, and E.F. Ellis Metabolism of arachidonic acid to epoxyeicosatrienoic acids. Hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes J Neurochem 61 1 1993 150 159
95. + signaling in perivascular astrocytes Am J Physiol Cell Physiol 299 5 2010 C1068 C1078
96. J. Capdevila, N. Chacos, J.R. Falck, S. Manna, A. Negro-Vilar, and S.R. Ojeda Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence Endocrinology 113 1 1983 421 423
97. X. Peng, C. Zhang, N.J. Alkayed, D.R. Harder, and R.C. Koehler Dependency of cortical functional hyperemia to forepaw stimulation on epoxygenase and nitric oxide synthase activities in rats J Cereb Blood Flow Metab 24 5 2004 509 517
98. J.J. Iliff, R. Wang, D.C. Zeldin, and N.J. Alkayed Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels Am J Physiol Heart Circ Physiol 296 5 2009 H1352 H1363
99. E. Abdu, D.A. Bruun, and D. Yang Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures J Neurochem 117 4 2010 632 642
100. B. Inceoglu, D. Zolkowska, and H.J. Yoo Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures PLoS ONE 8 12 2013 e80922
101. B. Inceoglu, K. Wagner, and N.H. Schebb Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP Proc Natl Acad Sci U S A 108 12 2011 5093 5097
102. C. Morisseau, and B.D. Hammock Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Annu Rev Pharmacool Toxicol 53 2013 37 58
103. J.D. Imig, X. Zhao, J.H. Capdevila, C. Morisseau, and B.D. Hammock Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension Hypertension 39 2 Pt 2 2002 690 694
104. B.D. Hammock, K. Wagner, and B. Inceoglu The soluble epoxide hydrolase as a pharmaceutical target for pain management Pain Magag 1 5 2011 383 386
105. K. Wagner, B. Inceoglu, and H. Dong Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models Eur J Pharmacol 700 1-3 2013 93 101
106. S.H. Hwang, K.M. Wagner, and C. Morisseau Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase J Med Chem 54 8 2011 3037 3050
107. B. Inceoglu, K.M. Wagner, and J. Yang Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes Proc Natl Acad Sci U S A 109 28 2012 11390 11395
108. K. Wagner, J. Yang, B. Inceoglu, and B.D. Hammock Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy J Pain Official J Am. Pain Soc. 15 9 2014 907 914
109. L. Davoody, R.L. Quiton, J.M. Lucas, Y. Ji, A. Keller, and R. Masri Conditioned place preference reveals tonic pain in an animal model of central pain J Pain 12 8 2011 868 874
110. K.J. Sufka Translational challenges and analgesic screening assays Pain 152 9 2011 1942 1943
111. A.G. Guedes, C. Morisseau, and A. Sole Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis Vet Anaesth Analg 40 4 2013 440 448
112. W. Zhang, I.P. Koerner, and R. Noppens Soluble epoxide hydrolase: a novel therapeutic target in stroke J Cereb Blood Flow Metab 27 12 2007 1931 1940
113. E. Abdu, D.A. Bruun, and D. Yang Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures J Neurochem 117 4 2011 632 642
114. H.J. Tsai, S.H. Hwang, and C. Morisseau Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs Eur J Pharm Sci 40 3 2010 222 238
115. A. Ulu, S. Appt, and C. Morisseau Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys Br J Pharmacol 165 5 2012 1401 1412
116. K.O. Aley, and J.D. Levine Rapid onset pain induced by intravenous streptozotocin in the rat J Pain 2 3 2001 146 150
117. E. Davidson, L. Coppey, and B. Lu The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy Exp Diabetes Res 2009 Article ID 431980